Related Experiment Videos
The Epstein-Barr virus: a group 1 carcinogen?
1Pathologisches Institut, Friedrich-Alexander-Universität, Erlangen. gerald.niedobitek@patho.med.uni-erlangen.de
Virchows Archiv : an International Journal of Pathology
|December 22, 1999
Summary
The Epstein-Barr virus (EBV), a human herpes virus, can transform B-lymphocytes. Evidence links EBV to various human cancers, leading to its classification as a group 1 carcinogen.
Area of Science:
- Virology
- Oncology
- Immunology
Background:
- Epstein-Barr virus (EBV) is a human herpesvirus.
- EBV possesses the ability to transform B-lymphocytes in vitro.
- EBV is associated with the pathogenesis of several human tumors.
Purpose of the Study:
- To review the evidence linking EBV to human carcinogenesis.
- To discuss EBV's role in the development of specific cancers.
Main Methods:
- Review of existing scientific literature and epidemiological data.
- Analysis of studies demonstrating EBV's association with tumor development.
Main Results:
- EBV is implicated in the development of Burkitt's lymphoma, Hodgkin's disease, and nasopharyngeal carcinoma.
- EBV's association with these cancers supports its carcinogenic potential.
- The International Agency for Research on Cancer classifies EBV as a group 1 carcinogen.
Conclusions:
- There is substantial evidence supporting EBV's role as a human carcinogen.
- Further research into EBV-associated cancers is warranted.
- Understanding EBV's oncogenic mechanisms is crucial for prevention and treatment strategies.